Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

Similar articles for PubMed (Select 23557078)

1.

Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study.

Kahrilas PJ, Howden CW, Wernersson B, Denison H, Nuevo J, Gisbert JP.

Aliment Pharmacol Ther. 2013 May;37(10):1005-10. doi: 10.1111/apt.12298. Epub 2013 Apr 5.

PMID:
23557078
2.

Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.

Kindt S, Imschoot J, Tack J.

Dis Esophagus. 2011 Nov;24(8):531-7. doi: 10.1111/j.1442-2050.2011.01189.x. Epub 2011 Mar 18.

PMID:
21418126
3.

Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy.

Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW.

Gut. 2014 May;63(5):720-6. doi: 10.1136/gutjnl-2013-304883. Epub 2013 Jul 5.

4.

Use of the Montreal global definition as an assessment of quality of life in reflux disease.

Sawaya RA, Macgill A, Parkman HP, Friedenberg FK.

Dis Esophagus. 2012 Aug;25(6):477-83. doi: 10.1111/j.1442-2050.2011.01271.x. Epub 2011 Oct 3.

5.

Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease.

Mearin F, Ponce J, Ponce M, Balboa A, Gónzalez MA, Zapardiel J.

Eur J Gastroenterol Hepatol. 2012 Jun;24(6):665-74. doi: 10.1097/MEG.0b013e3283512139.

PMID:
22330237
6.
7.

Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease.

Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW.

Clin Gastroenterol Hepatol. 2012 Jun;10(6):612-9. doi: 10.1016/j.cgh.2012.01.022. Epub 2012 Feb 14.

PMID:
22343515
8.

The burden of illness of gastro-oesophageal reflux disease: impact on work productivity.

Dean BB, Crawley JA, Schmitt CM, Wong J, Ofman JJ.

Aliment Pharmacol Ther. 2003 May 15;17(10):1309-17.

9.

Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease.

Jones R, Horbach S, Sander P, Rydén-Bergsten T.

Pharmacoeconomics. 2003;21(15):1091-102.

PMID:
14596628
10.

Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.

Johnson D, Crawley JA, Hwang C, Brown K.

Aliment Pharmacol Ther. 2010 Jul;32(2):182-90. doi: 10.1111/j.1365-2036.2010.04339.x. Epub 2010 Apr 29.

PMID:
20456306
13.

Impact of gastroesophageal reflux disease on daily life: the Systematic Investigation of Gastrointestinal Diseases in China (SILC) epidemiological study.

Wang R, Zou D, Ma X, Zhao Y, Yan X, Yan H, Fang J, Yin P, Kang X, Li Q, Dent J, Sung JJ, Halling K, Johansson S, Liu W, He J.

Health Qual Life Outcomes. 2010 Nov 10;8:128. doi: 10.1186/1477-7525-8-128.

14.

The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD.

Fass R, Johnson DA, Orr WC, Han C, Mody R, Stern KN, Pilmer BL, Perez MC.

Am J Gastroenterol. 2011 Mar;106(3):421-31. doi: 10.1038/ajg.2010.458. Epub 2011 Jan 11.

PMID:
21224838
15.

Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity.

Revicki DA, Zodet MW, Joshua-Gotlib S, Levine D, Crawley JA.

Health Qual Life Outcomes. 2003 Nov 29;1:73.

16.

Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity.

Dubois RW, Aguilar D, Fass R, Orr WC, Elfant AB, Dean BB, Harper AS, Yu HT, Melmed GY, Lynn R, Singh A, Tedeschi M.

Aliment Pharmacol Ther. 2007 Feb 15;25(4):487-500.

17.

Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease.

Peura DA, Pilmer B, Hunt B, Mody R, Perez MC.

Aliment Pharmacol Ther. 2013 Nov;38(10):1303-11. doi: 10.1111/apt.12504. Epub 2013 Sep 30.

PMID:
24118079
18.

Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.

Aanen MC, Weusten BL, Numans ME, de Wit NJ, Samsom M, Smout AJ.

J Clin Gastroenterol. 2008 May-Jun;42(5):441-7. doi: 10.1097/MCG.0b013e318074dd62.

PMID:
18344896
19.

Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting.

Gisbert JP, Cooper A, Karagiannis D, Hatlebakk J, Agréus L, Jablonowski H, Zapardiel J.

Health Qual Life Outcomes. 2009 Jul 2;7:60. doi: 10.1186/1477-7525-7-60.

20.

Prevalence, severity, and risk factors of symptomatic gastroesophageal reflux disease among employees of a large hospital in northern India.

Sharma PK, Ahuja V, Madan K, Gupta S, Raizada A, Sharma MP.

Indian J Gastroenterol. 2011 May;30(3):128-34. doi: 10.1007/s12664-010-0065-5.

PMID:
21061110
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk